Cite
Protective role of pretreatment with Anisodamine against sepsis-induced diaphragm atrophy via inhibiting JAK2/STAT3 pathway.
MLA
Wang, Yurou, et al. “Protective Role of Pretreatment with Anisodamine against Sepsis-Induced Diaphragm Atrophy via Inhibiting JAK2/STAT3 Pathway.” International Immunopharmacology, vol. 133, May 2024, p. 112133. EBSCOhost, https://doi.org/10.1016/j.intimp.2024.112133.
APA
Wang, Y., Chu, Y., Dai, H., Zheng, Y., Chen, R., Zhou, C., Zhong, Y., Zhan, C., & Luo, J. (2024). Protective role of pretreatment with Anisodamine against sepsis-induced diaphragm atrophy via inhibiting JAK2/STAT3 pathway. International Immunopharmacology, 133, 112133. https://doi.org/10.1016/j.intimp.2024.112133
Chicago
Wang, Yurou, Yun Chu, Hongkai Dai, Yingfang Zheng, Renyu Chen, Chenchen Zhou, Yanxia Zhong, Chengye Zhan, and Jinlong Luo. 2024. “Protective Role of Pretreatment with Anisodamine against Sepsis-Induced Diaphragm Atrophy via Inhibiting JAK2/STAT3 Pathway.” International Immunopharmacology 133 (May): 112133. doi:10.1016/j.intimp.2024.112133.